P2‐003: Clinical Trial Design of Cread: A Randomized, Double‐Blind, Placebo‐Controlled, Parallel‐Group Phase 3 Study to Evaluate Crenezumab Treatment in Patients with Prodromal‐To‐Mild Alzheimer’s Disease

Subjects

Subjects :

0301 basic medicine
medicine.medical_specialty
Epidemiology
business.industry
Health Policy
Clinical study design
Phases of clinical research
Disease
Placebo
Double blind
03 medical and health sciences
Psychiatry and Mental health
Cellular and Molecular Neuroscience
030104 developmental biology
0302 clinical medicine
Developmental Neuroscience
Internal medicine
Crenezumab
medicine
In patient
Neurology (clinical)
Geriatrics and Gerontology
business
030217 neurology & neurosurgery

Details

ISSN :

15525279 and 15525260

Volume :

12

Database :

OpenAIRE

Journal :

Alzheimer's & Dementia

Accession number :

edsair.doi...........964a58c30c08c3564a1be6e213368ca2

Full Text :

https://doi.org/10.1016/j.jalz.2016.06.1207